ER estrogen receptor, DCIS ductal carcinoma in situ, HER2 human epidermal growth factor receptor 2, NST no special type, IQR interquartile range, PR progesterone receptor, TNBC triple-negative breast cancer. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.